TTNP icon

Titan Pharmaceuticals
TTNP

Overview Fund Activity

27 hedge funds and large institutions have $498K invested in Titan Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 3 closing their positions.

Holders
27
Holders Change
+2
Holders Change %
+8%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$28.9K
2
Geode Capital Management
2
Geode Capital Management
Massachusetts
$40.9K
3
TSS
3
Two Sigma Securities
New York
$9.34K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$64K
5
JPMorgan Chase & Co
5
JPMorgan Chase & Co
New York
$73

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$0
2
Group One Trading
2
Group One Trading
Illinois
$107
Name Market Value Shares Shares
Change 		Shares
Change %
Carson Wealth (CWM LLC)
26
Carson Wealth (CWM LLC)
Nebraska
– – -2 Closed
Acadian Asset Management
27
Acadian Asset Management
Massachusetts
– – -1 Closed
CFGS
28
Concourse Financial Group Securities
Alabama
– – – –
CIA
29
Cape Investment Advisory
Georgia
$0 1 – –
DJSG
30
D.J. St. Germain
Massachusetts
$0 1 – –
MFA
31
McClarren Financial Advisors
Pennsylvania
$0 3 +3 New
1
2